By Nonish / 27th July 2026
NSCLC (Non-Small Cell Lung Cancer) is one of the most common forms of lung cancer. In the last several decades, there have been many advancements in the treatment of the disease, especially through the development of targeted therapies, which target specific genetic changes that occur in the cancer cells. Understanding NSCLC, causes of NSCLC, symptoms of NSCLC, and potential NSCLC treatments would be of great advantage to the patients and their families.
NSCLC is caused due to the uncontrolled growth of abnormal cells in the lungs. There are many sub-types of NSCLC such as adenocarcinoma and squamous cell carcinoma. It is generally slower to progress than other forms of lung cancer which making it difficult to diagnose.
NSCLC is usually associated with various risk factors. Smoking is the most typical one, but it is not the only one. It is possible for even those individuals who do not smoke at all to suffer from this problem. Some various factors also cause the disease, such as:
Initially, NSCLC does not have clear symptoms making its detection difficult. However, as the disease advances, the following symptoms may emerge:
● Coughing
● Pain in the chest area
● Difficult breathing
● Feeling fatigued
● Unexpected weight loss
● Blood in the sputum
Detecting the above symptoms on time is important for the early treatment of NSCLC.
There are a variety of tests that can be done to diagnose non-small cell lung cancer. The important diagnostic tests include the following:
CT Scan: Used to find any abnormality within the lungs by x-rays.
Biopsy: Used to confirm cancerous cells within the body by taking a small sample of tissue or cells from the body.
Gene Mutations: Used to detect any gene mutation.
There have been changes in the treatment of NSCLC since the introduction of targeted therapy. While other treatments affect SEVERAL cell undergoing rapid division, this treatment only targets the mutation of genes responsible for the development of cancer cells. Patients whose mutations include ALK or EGFR respond best to these therapies as they inhibit the signals allowing cancer cells to develop.
Before beginning treatment, it is important to conduct molecular testing. This will enable the doctors to know the specific type of mutation that is present in the cancerous cells, therefore selecting the most appropriate form of treatment. Failure to conduct molecular testing can render the treatment ineffective.
The use of targeted drugs is important in NSCLC patients since they act directly on the gene mutation existing in the cancer cells. Identify the following targeted medicines which are mostly prescribed by the doctors:
Alectinib is the standard medication for ALK-positive NSCLC. It acts on pathways that facilitate tumor growth and progression.
Brand:
ALECENSA 150mg capsules, ALECNIB 150mg capsules
Benefits:
Side effects to be noticed:
Mobocertinib medication was developed for patients with particular EGFR exon 20 insertions mutation, which are difficult to manage with other means.
Brand:
EXKIVITY 40mg, MOBOXEN 40mg
Benefits:
Side Effects:
The future of the treatment of NSCLC lies in the advent of precision medicine. Through constant research, there will be new treatments that will target the cancer cells specifically while at the same time reducing side effects. However, new discoveries in genetic testing have made it possible for patients to get customized treatment plans.
NSCLC is a life-threatening disease; however, new developments in the field of targeted treatment have significantly improved the situation. Timely diagnosis, accurate assessment, and personalized treatment are essential factors for better results. With the current developments in precision medicine, patients can now get treatment that is more effective and customized compared to previous years.
1. Would the targeted therapy be useful for everybody?
Not really, since these therapies would only work for people who have certain mutations. Tests would be needed to check their eligibility.
2. How long should the treatment going of NSCLC?
It all depends on the stage of cancer and the patient’s reaction to the treatment. Sometimes, the patients would require prolonged treatment.
References